fbpx
QQQ
-8.42
333.73
-2.59%
DIA
-6.69
349.57
-1.95%
SPY
-8.57
422.85
-2.07%
TLT
-1.44
138.48
-1.05%
GLD
-1.68
173.80
-0.98%

Most Recent News

Pure Extracts Cannabis & Hemp Co. Debuts Functional Mushrooms Products On Amazon

Pure Extracts Technologies Corp. read more

Exclusive: Silo Wellness To Launch 5-MeO-DMT Psychedelic Retreats In Jamaica

Psychedelics company Silo Wellness Inc. (FRA: 3K70) (Canadian Securities Exchange: SILO) will expand its portfolio of psilocybin and ketamine product and retreat offerings to include 5-MeO-DMT, Benzinga has learned exclusively ahead of an official announcement. read more

Wesana Health Goes Public, Looks At Psychedelics As Treatment For Traumatic Brain Injury

On Monday, Wesana Health Holdings Inc. announced that its shares began trading on the Canadian Securities Exchange under the ticker symbol “WESA.” The company, founded by former NHL left-winger Daniel Carcillo, is focused on finding novel solutions for treating traumatic brain injury (TBI) through psychedelics and naturally sourced therapies. read more

Video: Experts Discuss Use Of Psychedelics In Mental Health Settings

The psychedelics industry has started to gain serious traction and is attracting lots of attention these days. However, what many people may not know is that the sector has been up and running for decades, with various psychedelic substances already being used for medical treatment. read more

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More

This was an eventful week for the cannabis industry. read more

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap. In This Week’s Edition, We Recap and Countdown the Top 10 Cannabis and Psychedelic Stock News Stories for the Week of May 3rd – 9th, 2021. read more

Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap. read more

Psyched: Groundbreaking Phase 3 Results On MDMA, Small Pharma, Wesana Go Public, Gilgamesh Raises $27M

Last week, the psychedelics space was moved by results from the world’s first Phase 3 clinical study of a scheduled psychedelic compound. read more

Canadian Farmers Markets Want To Sell Cannabis

This article by Johnny Green was originally published on Cannabis & Tech Today, and appears here with permission. read more

The Benefits Of Peyote: Ancient Wisdom, Modern Medicine

This article by Evan Lewis-Healey was originally published on Psychedelic Spotlight, and appears here with permission. read more

How Psychedelics Without Hallucinogenic Effects Could Revolutionize Psychiatry

A new study published in the peer-review journal Cell looks at a novel compound capable of providing some of the therapeutic properties of psychedelics without hallucinations. read more

Novamind And Field Trip Expand Footprint Of Psychedelic Clinics

Novamind Inc. (OTCPink: NVMDF), a company specializing in mental health and psychedelics treatment, announced on Tuesday it intends to open four new psychiatry clinics in Utah. read more

Video: The Psychedelics Market With Entheon Biomedical, MagicMed, Natan Ponieman

Benzinga’s Cannabis Hour is a live show for cannabis investors. read more

World's First Phase 3 Clinical Trial On MDMA Shows 'Powerful New Pathway To Healing'

The results from the world’s first Phase 3 clinical study on a psychedelic are in — and they’re significant. The Multidisciplinary Association for Psychedelic Studies released the results from its Phase 3 trial on MDMA for the treatment of post-traumatic stress disorder.  read more

Gilgamesh Pharmaceuticals Raises $27M In Series A With Prime Movers Lab

Gilgamesh Pharmaceuticals, a biotechnology company that uses psychedelic-related drugs to treat neuropsychiatric disorders, reported Thursday it has raised $27 million in a Series A funding round led by Prime Movers Lab. read more